NDC 58354-117

Dyrax-Q Tab

Bisacodyl, Docusate Sodium

Dyrax-Q Tab is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Cho-a Pharm.co.,ltd.. The primary component is Bisacodyl; Docusate Sodium.

Product ID58354-117_95fe3aa6-6654-64bf-e053-2995a90ab91c
NDC58354-117
Product TypeHuman Otc Drug
Proprietary NameDyrax-Q Tab
Generic NameBisacodyl, Docusate Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-10-25
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NameCho-A Pharm.Co.,Ltd.
Substance NameBISACODYL; DOCUSATE SODIUM
Active Ingredient Strength5 mg/161mg; mg/161mg
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC SPL Data Element Entries

NDC 58354-117-01 [58354011701]

Dyrax-Q Tab TABLET
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-10-25

NDC 58354-117-02 [58354011702]

Dyrax-Q Tab TABLET
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-10-25
Marketing End Date2019-10-26

Drug Details

Active Ingredients

IngredientStrength
BISACODYL5 mg/161mg

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.